1. The roles of the thioredoxin system and peroxiredoxins in 1-methyl-4-phenyl-pyridinium ion-induced cytotoxicity in rat pheochromocytoma cells.
- Author
-
Chen VT, Huang CL, Lee YC, Liao WC, and Huang NK
- Subjects
- Animals, Apoptosis drug effects, Cell Survival drug effects, Lipid Peroxidation drug effects, Membrane Potential, Mitochondrial drug effects, Oxidation-Reduction drug effects, PC12 Cells, Pheochromocytoma metabolism, Pheochromocytoma pathology, Poly (ADP-Ribose) Polymerase-1, Poly(ADP-ribose) Polymerases metabolism, Rats, Reactive Oxygen Species metabolism, Superoxides metabolism, Tetrazolium Salts metabolism, Thiazoles metabolism, Tumor Stem Cell Assay, 1-Methyl-4-phenylpyridinium toxicity, Antineoplastic Agents pharmacology, Peroxiredoxins metabolism, Pheochromocytoma drug therapy, Thioredoxins metabolism
- Abstract
The 1-methyl-4-phenyl-pyridinium ion (MPP(+)), an active metabolite of the neurotoxin, N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), induces death in rat pheochromocytoma (PC12) cells, suggesting a cell model of Parkinson's disease (PD). However, most of the toxic mechanisms remain illusive. In this study, we have found that MPP(+) induced apoptotic cell death in PC12 cells as measured by the MTT assay and annexin V-FITC staining. Besides, MPP(+) also resulted in decreased mitochondrial membrane potential and increased mitochondrial free radical formation as imaged by the staining of TMRE or MitoSOX, respectively, confirming the neurotoxic effect of MPP(+) by interfering with mitochondrial functions. Western blot analysis indicated that MPP(+) differentially regulated the expressions and over-oxidation of thioredoxin systems and peroxiredoxins. Since these enzymes are known to prevent oxidative stress and apoptosis, these evidences could be regarded as a novel neurotoxic mechanism of MPP(+) and also provide an alternative view of developing drug therapies for PD., (Copyright 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF